Log In
Print this Print this

Xarelto, rivaroxaban (BAY 59-7939)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionDirect Factor Xa inhibitor
Molecular Target Factor Xa
Mechanism of ActionFactor Xa inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today